
Qpex Biopharmarevenue & acquisition
San Diego, CaliforniaFounded 2018
Qpex Biopharma was acquired.
Qpex Biopharma, Inc. is a clinical-stage biopharmaceutical company committed to improving patient care across inpatient and outpatient settings, focusing on developing new antibiotics to combat the growing threat of global antimicrobial resistance.
Qpex Biopharma revenue
Qpex Biopharma has not published its revenue. Growjo puts it at about $7.4M a year (September 2024).
| As of | Revenue | Source |
|---|---|---|
| Sep 2024 | $7.4MEST | Growjo estimate |
Who owns Qpex Biopharma
Another company owns Qpex Biopharma. The date and price of the deal are not on record.
Qpex Biopharma CEO
Michael Dudley was CEO of Qpex Biopharma.
Categories
How this page is sourced
1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Qpex Biopharma? Join the podcast